Home Cart Sign in  
Chemical Structure| 22978-25-2 Chemical Structure| 22978-25-2

Structure of GW9662
CAS No.: 22978-25-2

Chemical Structure| 22978-25-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GW9662 is a PPARγ antagonist with high selectivity for PPARγ, with an IC50 value of 3.3 nM. GW9662 has antidiabetic and anti-inflammatory effects and can be used in research on metabolic diseases and inflammatory disorders.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GW9662

CAS No. :22978-25-2
Formula : C13H9ClN2O3
M.W : 276.68
SMILES Code : O=C(NC1=CC=CC=C1)C2=CC([N+]([O-])=O)=CC=C2Cl
MDL No. :MFCD01215270
InChI Key :DNTSIBUQMRRYIU-UHFFFAOYSA-N
Pubchem ID :644213

Safety of GW9662

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • PPARγ

    PPARγ, IC50:3.3 nM

  • PPARα

    PPARα, IC50:32 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Human T cells 10 µM 4 days To evaluate the effect of GW9662 on the differentiation of human T cells into regulatory T cells (Tregs), results showed that GW9662 inhibited Treg differentiation. PMC10229556
CGNPs 50 nM and 100 nM 24 h GW9662 treatment resulted in a significant reduction of PPARγ, accompanied by decreased levels of HKII, PKM2, and Glut4, indicating that PPARγ activity is required for glycolysis and ongoing cell division PMC3306783
human mesenchymal stem cells (hMSCs) 10 μM 8 days Enhancing Wnt signaling and osteogenesis in hMSCs by inhibiting PPARγ PMC5309156

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice CTCF-deficient mice Injection 100 μM Daily for 2 weeks Inhibition of PPARγ by GW9662 significantly reduced the expression of CD36 and lipid accumulation in the livers of CTCF-deficient mice PMC8551791
SKH-1 hairless mice UVB-induced skin cancer model Topical or intraperitoneal injection 1.5, 15 or 150 nmoles (topical) or 1 or 5 mg/kg (ip) 24 hours or 72 hours GW9662 treatment resulted in increased UVB-induced apoptosis and inflammation PMC4280796
Mice C57BL/6 mice Intragastric administration 5 mg/kg Once daily for 3 days GW9662 significantly increased the overall number of E. coli recovered from the colon of mice and drove a nitrate respiration-dependent E. coli expansion. PMC5642957
Mice Experimental autoimmune encephalomyelitis (EAE) model Intraperitoneal injection 2 mg/kg Daily for 28 days To evaluate the effect of GW9662 on disease severity in the EAE model, results showed that GW9662 reduced EAE disease severity and decreased the frequency of peripheral Tregs. PMC10229556
Mice Hepatic ischemia/reperfusion injury model Intraperitoneal injection 1.0mg/kg Single injection, lasting 30 minutes GW9662 was used to block PPAR γ activity, and the results showed that the protective effect of 15d-PGJ2 against hepatic ischemia/reperfusion injury is not dependent on PPAR γ. PMC4047210
mice NeuroD2-SmoA1 mice intraperitoneal injection 10 mg/kg once daily for 8 days GW9662 treatment significantly reduced levels of glycolytic markers and cyclin D2, and extended the survival of medulloblastoma-bearing mice PMC3306783
Mice Intracerebral hemorrhage model Intraperitoneal injection 5 mg/kg Once daily until euthanasia GW9662 treatment decreased rosiglitazone-induced expression of alternative activation markers (especially IL-10) and abolished PPAR γ-mediated hematoma resolution. PMC5540140

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.61mL

0.72mL

0.36mL

18.07mL

3.61mL

1.81mL

36.14mL

7.23mL

3.61mL

References

 

Historical Records

Categories